Pluribus Labs’s Dentsply Sirona XRAY Stock Holding History

Pluribus Labs’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,639	Closed	-$315K	–	225
2021 Q4	$315K	Buy	+5,639	New	+$310K	0.33%	126

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Pluribus Labs's XRAY Position: Q1 2022 in Review

Pluribus Labs sold out of Dentsply Sirona (XRAY) in Q1 2022, closing a stake of 5,639 shares — an estimated $315K sold.

Pluribus Labs first reported a position in XRAY in Q4 2021 and held it in 1 quarter. The position peaked at $315K in Q4 2021. 536 funds tracked by Wall St. Rank hold XRAY as of Q1 2022.

Pluribus Labs reported no remaining Dentsply Sirona position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 5,639 Dentsply Sirona shares in Q1 2022, an estimated $315K.
Pluribus Labs first reported a position in Dentsply Sirona in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Dentsply Sirona position peaked at $315K in Q4 2021.
536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.